Accredo Pharma Science Private Limited, a active private limited company, was established on 30 December 2011 in Perambur Purasawalkam, Tamil Nadu, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74900TN2011PTC083825. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹11.00 Cr and a paid-up capital of ₹1.96 Cr.
It upholds a compliant status. Employing 4 professional, Its leadership includes Chittibabu Sarathchandran (Additional Director), Jain Arihant Kumar Narendrakumar (Managing Director), Subramanian Murali (Whole-Time Director). Past directors included Richard Jeyaseelan, Chittibabu Sarathchandran, Jain Arihant Kumar Narendrakumar. It holds ₹10.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at New No. 14, Old No. 25/1, J Block, Perambur Purasawalkam, Tamil Nadu, 600102.
U74900TN2011PTC083825
083825
30 December 2011
₹11.00 Cr
₹1.96 Cr
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Accredo Pharma Science Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Chittibabu Sarathchandran | Additional Director | 08 May 2015 | Current |
| Jain Arihant Kumar Narendrakumar | Managing Director | 08 May 2015 | Current |
| Subramanian Murali | Whole-Time Director | 11 Oct 2021 | Current |
| Siroya Rajeshkumar | Director | 27 Mar 2018 | Current |
| Soniya Jain | Additional Director | 16 Apr 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Nov 2020 | Past |
| Pramod Abcsdd | Additional Director | 27 Mar 2018 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2022 | Past |
| Pramod Abcsdd | Director | 08 May 2015 | Past |
| Pramod Abcsdd | Director | 18 Dec 2021 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Accredo Pharma Science Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 16.11% increase. The company also saw a substantial fall in profitability, with a 31.58% decrease in profit. The company's net worth Soared by an impressive increase of 22.28%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Accredo Pharma Science had a public holding of 21.94%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹100,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Feb 2021 | Others | ₹10.00 Cr | Open |
Explore comprehensive loan charge details -
Accredo Pharma Science has a workforce of 4 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Accredo Pharma Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Accredo Pharma Science's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Others of Rs. 10.00 Cr registered on 01 Feb 2021 with Charge ID 100436450 was modified on 25 Aug 2025. was documented.
Soniya Jain was appointed as a Additional Director was appointed as a Additional Director on 16 Apr 2025 & has been associated with this company since 7 months 14 days . was recorded as a recent event.
The activity Accredo Pharma Science Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Accredo Pharma Science Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was documented.
The activity Subramanian Murali was appointed as a Whole-time director was appointed as a Whole-time director on 11 Oct 2021 & has been associated with this company since 4 years 1 month . was completed.
The activity A charge with Others amounted to Rs. 10.00 Cr with Charge ID 100436450 was registered on 01 Feb 2021. was completed.
The CIN of Accredo Pharma Science Private Limited is U74900TN2011PTC083825.
Accredo Pharma Science Private Limited is headquartered at New No. 14, Old No. 25/1, J Block, Perambur Purasawalkam, Tamil Nadu, 600102.
Accredo Pharma Science Private Limited was incorporated on 30 December 2011.
The current directors of Accredo Pharma Science Private Limited are
The primary industry of Accredo Pharma Science Private Limited is Trade.
Accredo Pharma Science Private Limited is unlisted.
The authorized capital of Accredo Pharma Science Private Limited is ₹11.00 Cr, and the paid-up capital is ₹1.96 Cr.
The compliance status of Accredo Pharma Science Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX